0001127602-23-015948.txt : 20230517
0001127602-23-015948.hdr.sgml : 20230517
20230517163627
ACCESSION NUMBER: 0001127602-23-015948
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230515
FILED AS OF DATE: 20230517
DATE AS OF CHANGE: 20230517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maunsell Farris Maryanne
CENTRAL INDEX KEY: 0001950052
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 23932302
MAIL ADDRESS:
STREET 1: C/O HAEMONETICS CORPORATION
STREET 2: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0401
BUSINESS ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-05-15
0000313143
HAEMONETICS CORP
HAE
0001950052
Maunsell Farris Maryanne
125 SUMMER STREET
BOSTON
MA
02110
1
VP, Chief Accounting Officer
0
Common Stock
2023-05-15
4
A
0
630
A
630
D
Non-qualified Stock Option (Right to Buy)
89.16
2023-05-15
4
A
0
1425
0
A
2030-05-15
Common Stock
1425
1425
D
The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.
Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
/s/ Thomas V. Powers, attorney-in-fact for Ms. Farris
2023-05-17